Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Lebetin 2, a Snake Venom-Derived B-Type Natriuretic Peptide, Provides Immediate and Prolonged Protection against Myocardial Ischemia-Reperfusion Injury via Modulation of Post-Ischemic Inflammatory Response.

Tourki B, Dumesnil A, Belaidi E, Ghrir S, Godin-Ribuot D, Marrakchi N, Richard V, Mulder P, Messadi E.

Toxins (Basel). 2019 Sep 10;11(9). pii: E524. doi: 10.3390/toxins11090524.

2.

Zinc deficiency promotes endothelin secretion and endothelial cell migration through nuclear hypoxia-inducible factor-1 translocation.

Morand J, Briançon-Marjollet A, Lemarie E, Gonthier B, Arnaud J, Korichneva I, Godin-Ribuot D.

Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C270-C276. doi: 10.1152/ajpcell.00460.2018. Epub 2019 May 22.

PMID:
31116583
3.

Chronic neuromuscular electrical stimulation improves muscle mass and insulin sensitivity in a mouse model.

Lotri-Koffi A, Pauly M, Lemarié E, Godin-Ribuot D, Tamisier R, Pépin JL, Vivodtzev I.

Sci Rep. 2019 May 10;9(1):7252. doi: 10.1038/s41598-019-43696-4.

4.

Targeting intermittent hypoxia downstream pathways for biomarker discovery and new treatment perspectives in cutaneous melanoma.

Minovès M, Pépin JL, Godin-Ribuot D.

Eur Respir J. 2019 Jan 31;53(2). pii: 1802444. doi: 10.1183/13993003.02444-2018. Print 2019 Feb. No abstract available.

PMID:
30769330
5.

Chronic Intermittent Hypoxia Alters Rat Ophthalmic Artery Reactivity Through Oxidative Stress, Endothelin and Endothelium-Derived Hyperpolarizing Pathways.

Mentek M, Morand J, Baldazza M, Faury G, Aptel F, Pepin JL, Godin-Ribuot D, Chiquet C.

Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5256-5265. doi: 10.1167/iovs.18-25151.

PMID:
30383197
6.

Response to letter to editor "Optical coherence tomography (OCT) findings in obstructive sleep apnea" by Piotr Kanclerz.

Mentek M, Aptel F, Godin-Ribuot D, Tamisier R, Pepin JL, Chiquet C.

Sleep Med Rev. 2018 Dec;42:232-233. doi: 10.1016/j.smrv.2018.08.007. Epub 2018 Aug 31. No abstract available.

PMID:
30274745
7.

Concerning "Comments and question on "Selective inhibition of endothelial NF-kB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice" ".

Arnaud C, Belaïdi-Corsat E, Godin-Ribuot D.

Atherosclerosis. 2018 Oct;277:227-228. doi: 10.1016/j.atherosclerosis.2018.06.862. Epub 2018 Jun 18. No abstract available.

PMID:
29961598
8.

Structural heterogeneity of the rat pulmonary vein myocardium: consequences on intracellular calcium dynamics and arrhythmogenic potential.

Pasqualin C, Yu A, Malécot CO, Gannier F, Cognard C, Godin-Ribuot D, Morand J, Bredeloux P, Maupoil V.

Sci Rep. 2018 Feb 19;8(1):3244. doi: 10.1038/s41598-018-21671-9.

9.

Chronic intermittent hypoxia promotes myocardial ischemia-related ventricular arrhythmias and sudden cardiac death.

Morand J, Arnaud C, Pepin JL, Godin-Ribuot D.

Sci Rep. 2018 Feb 14;8(1):2997. doi: 10.1038/s41598-018-21064-y.

10.

Diseases of the retina and the optic nerve associated with obstructive sleep apnea.

Mentek M, Aptel F, Godin-Ribuot D, Tamisier R, Pepin JL, Chiquet C.

Sleep Med Rev. 2018 Apr;38:113-130. doi: 10.1016/j.smrv.2017.05.003. Epub 2017 May 29. Review.

PMID:
29107469
11.

Chronic Intermittent Hypoxia Impairs Insulin Sensitivity but Improves Whole-Body Glucose Tolerance by Activating Skeletal Muscle AMPK.

Thomas A, Belaidi E, Moulin S, Horman S, van der Zon GC, Viollet B, Levy P, Bertrand L, Pepin JL, Godin-Ribuot D, Guigas B.

Diabetes. 2017 Dec;66(12):2942-2951. doi: 10.2337/db17-0186. Epub 2017 Sep 7.

12.

An innovative intermittent hypoxia model for cell cultures allowing fast Po2 oscillations with minimal gas consumption.

Minoves M, Morand J, Perriot F, Chatard M, Gonthier B, Lemarié E, Menut JB, Polak J, Pépin JL, Godin-Ribuot D, Briançon-Marjollet A.

Am J Physiol Cell Physiol. 2017 Oct 1;313(4):C460-C468. doi: 10.1152/ajpcell.00098.2017. Epub 2017 Jul 26.

13.

Intermittent hypoxia in obese Zucker rats: cardiometabolic and inflammatory effects.

Briançon-Marjollet A, Monneret D, Henri M, Joyeux-Faure M, Totoson P, Cachot S, Faure P, Godin-Ribuot D.

Exp Physiol. 2016 Nov 1;101(11):1432-1442. doi: 10.1113/EP085783. Epub 2016 Oct 5.

14.

Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion.

Tourki B, Matéo P, Morand J, Elayeb M, Godin-Ribuot D, Marrakchi N, Belaidi E, Messadi E.

PLoS One. 2016 Sep 12;11(9):e0162632. doi: 10.1371/journal.pone.0162632. eCollection 2016.

15.

Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Belaidi E, Morand J, Gras E, Pépin JL, Godin-Ribuot D.

Pharmacol Ther. 2016 Dec;168:1-11. doi: 10.1016/j.pharmthera.2016.07.010. Epub 2016 Aug 2. Review.

16.

Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.

Thomas A, Belaidi E, Aron-Wisnewsky J, van der Zon GC, Levy P, Clement K, Pepin JL, Godin-Ribuot D, Guigas B.

Sci Rep. 2016 Apr 20;6:24618. doi: 10.1038/srep24618.

17.

Endoplasmic reticulum stress as a novel inducer of hypoxia inducible factor-1 activity: its role in the susceptibility to myocardial ischemia-reperfusion induced by chronic intermittent hypoxia.

Belaidi E, Thomas A, Bourdier G, Moulin S, Lemarié E, Levy P, Pépin JL, Korichneva I, Godin-Ribuot D, Arnaud C.

Int J Cardiol. 2016 May 1;210:45-53. doi: 10.1016/j.ijcard.2016.02.096. Epub 2016 Feb 17.

PMID:
26922713
18.

Endothelin-1 mediates intermittent hypoxia-induced inflammatory vascular remodeling through HIF-1 activation.

Gras E, Belaidi E, Briançon-Marjollet A, Pépin JL, Arnaud C, Godin-Ribuot D.

J Appl Physiol (1985). 2016 Feb 15;120(4):437-43. doi: 10.1152/japplphysiol.00641.2015. Epub 2015 Dec 17.

19.

Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase.

Briançon-Marjollet A, Monneret D, Henri M, Hazane-Puch F, Pepin JL, Faure P, Godin-Ribuot D.

J Physiol. 2016 Mar 15;594(6):1727-40. doi: 10.1113/JP271321. Epub 2016 Jan 20.

20.

Comparison of continuous positive airway pressure and bosentan effect in mildly hypertensive patients with obstructive sleep apnoea: A randomized controlled pilot study.

Joyeux-Faure M, Jullian-Desayes I, Pepin JL, Cracowski JL, Baguet JP, Tamisier R, Levy P, Godin-Ribuot D, Launois SH.

Respirology. 2016 Apr;21(3):546-52. doi: 10.1111/resp.12713. Epub 2015 Dec 8.

21.

Compact Laser Doppler Flowmeter (LDF) Fundus Camera for the Assessment of Retinal Blood Perfusion in Small Animals.

Mentek M, Truffer F, Chiquet C, Godin-Ribuot D, Amoos S, Loeuillet C, Bernabei M, Geiser M.

PLoS One. 2015 Jul 30;10(7):e0134378. doi: 10.1371/journal.pone.0134378. eCollection 2015.

22.

Hypoxic Conditioning as a New Therapeutic Modality.

Verges S, Chacaroun S, Godin-Ribuot D, Baillieul S.

Front Pediatr. 2015 Jun 22;3:58. doi: 10.3389/fped.2015.00058. eCollection 2015. Review.

23.

The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms.

Briançon-Marjollet A, Weiszenstein M, Henri M, Thomas A, Godin-Ribuot D, Polak J.

Diabetol Metab Syndr. 2015 Mar 24;7:25. doi: 10.1186/s13098-015-0018-3. eCollection 2015.

24.

Effect of continuous vs pulsed iontophoresis of treprostinil on skin blood flow.

Kotzki S, Roustit M, Arnaud C, Godin-Ribuot D, Cracowski JL.

Eur J Pharm Sci. 2015 May 25;72:21-6. doi: 10.1016/j.ejps.2015.02.012. Epub 2015 Feb 21.

PMID:
25712367
25.

Erectile dysfunction and obstructive sleep apnea: from mechanisms to a distinct phenotype and combined therapeutic strategies.

Pépin JL, Tamisier R, Godin-Ribuot D, Lévy PA.

Sleep Med Rev. 2015 Apr;20:1-4. doi: 10.1016/j.smrv.2014.12.004. Epub 2014 Dec 27. No abstract available.

PMID:
25613436
26.

Sleep apnoea and cancer: the new challenge.

Lévy P, Godin-Ribuot D, Pepin JL.

Eur Respir J. 2014 Jun;43(6):1567-70. doi: 10.1183/09031936.00065714. No abstract available.

27.

Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.

Kalakech H, Tamareille S, Pons S, Godin-Ribuot D, Carmeliet P, Furber A, Martin V, Berdeaux A, Ghaleh B, Prunier F.

J Mol Cell Cardiol. 2013 Dec;65:98-104. doi: 10.1016/j.yjmcc.2013.10.001. Epub 2013 Oct 17.

PMID:
24140799
28.

Anodal iontophoresis of a soluble guanylate cyclase stimulator induces a sustained increase in skin blood flow in rats.

Kotzki S, Roustit M, Arnaud C, Boutonnat J, Blaise S, Godin-Ribuot D, Cracowski JL.

J Pharmacol Exp Ther. 2013 Sep;346(3):424-31. doi: 10.1124/jpet.113.205484. Epub 2013 Jul 9.

PMID:
23838678
29.

Iontophoresis of endothelin receptor antagonists in rats and men.

Roustit M, Blaise S, Arnaud C, Hellmann M, Millet C, Godin-Ribuot D, Dufournet B, Boutonnat J, Ribuot C, Cracowski JL.

PLoS One. 2012;7(7):e40792. doi: 10.1371/journal.pone.0040792. Epub 2012 Jul 13.

30.

Sleep deprivation, sleep apnea and cardiovascular diseases.

Levy P, Tamisier R, Arnaud C, Monneret D, Baguet JP, Stanke-Labesque F, Dematteis M, Godin-Ribuot D, Ribuot C, Pepin JL.

Front Biosci (Elite Ed). 2012 Jan 1;4:2007-21. Review.

PMID:
22202016
31.

Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia.

Ramond A, Godin-Ribuot D, Ribuot C, Totoson P, Koritchneva I, Cachot S, Levy P, Joyeux-Faure M.

Fundam Clin Pharmacol. 2013 Jun;27(3):252-61. doi: 10.1111/j.1472-8206.2011.01015.x. Epub 2011 Dec 7.

PMID:
22145601
32.

Delayed myocardial preconditioning induced by cobalt chloride in the rat: HIF-1α and iNOS involvement.

Belaidi E, Beguin PC, Levy P, Ribuot C, Godin-Ribuot D.

Fundam Clin Pharmacol. 2012 Aug;26(4):454-62. doi: 10.1111/j.1472-8206.2011.00940.x. Epub 2011 Apr 11.

PMID:
21480981
33.

[The endothelin system: its involvement in the cardiovascular system].

Belaidi E, Godin-Ribuot D.

Rev Med Interne. 2010 Nov;31(11):792-4. doi: 10.1016/j.revmed.2009.11.011. Epub 2010 Jun 8. French.

PMID:
20570418
34.

Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients.

Monneret D, Pepin JL, Godin-Ribuot D, Ducros V, Baguet JP, Levy P, Faure P.

Free Radic Biol Med. 2010 Feb 15;48(4):619-25. doi: 10.1016/j.freeradbiomed.2009.12.008. Epub 2009 Dec 16.

PMID:
20025964
35.

Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease.

Dematteis M, Godin-Ribuot D, Arnaud C, Ribuot C, Stanke-Labesque F, Pépin JL, Lévy P.

ILAR J. 2009;50(3):262-81. Review.

PMID:
19506313
36.

Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea.

Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Levy P, Godin-Ribuot D.

J Am Coll Cardiol. 2009 Apr 14;53(15):1309-17. doi: 10.1016/j.jacc.2008.12.050.

37.

Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives.

Lévy P, Pépin JL, Arnaud C, Tamisier R, Borel JC, Dematteis M, Godin-Ribuot D, Ribuot C.

Eur Respir J. 2008 Oct;32(4):1082-95. doi: 10.1183/09031936.00013308. Review.

38.

Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat.

Belaidi E, Beguin PC, Levy P, Ribuot C, Godin-Ribuot D.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H901-8. Epub 2007 Dec 14.

39.

Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2.

Béguin PC, Belaidi E, Godin-Ribuot D, Lévy P, Ribuot C.

J Mol Cell Cardiol. 2007 Feb;42(2):343-51. Epub 2006 Dec 22.

PMID:
17188294
40.

[Hypoxic preconditioning: role of transcription factor HIF-1alpha].

Belaïdi E, Béguin PC, Ribuot C, Godin-Ribuot D.

Ann Cardiol Angeiol (Paris). 2006 Apr;55(2):70-3. Review. French.

PMID:
16708989
41.

Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart.

Joyeux-Faure M, Ramond A, Béguin PC, Belaïdi E, Godin-Ribuot D, Ribuot C.

Fundam Clin Pharmacol. 2006 Feb;20(1):51-6.

PMID:
16448394
42.

Erythropoietin and myocardial protection: what's new?

Joyeux-Faure M, Godin-Ribuot D, Ribuot C.

Fundam Clin Pharmacol. 2005 Aug;19(4):439-46. Review.

PMID:
16011730
43.

Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat.

Lefebvre B, Godin-Ribuot D, Joyeux-Faure M, Caron F, Bessard G, Lévy P, Stanke-Labesque F.

Respir Physiol Neurobiol. 2006 Feb 28;150(2-3):278-86. Epub 2005 Jun 24.

PMID:
15979951
44.

Acute intermittent hypoxia improves rat myocardium tolerance to ischemia.

Béguin PC, Joyeux-Faure M, Godin-Ribuot D, Lévy P, Ribuot C.

J Appl Physiol (1985). 2005 Sep;99(3):1064-9. Epub 2005 May 5.

45.

15-F-isoprostane and 5-F-isoprostane are not triggers of myocardial preconditioning.

Arnaud C, Cracowski JL, Hakim A, Durand T, Guy A, Godin-Ribuot D, Bessard G, Ribuot C.

Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):350-4.

46.

[Cardiac and vascular effects of cannabinoids: toward a therapeutic use?].

Ribuot C, Lamontagne D, Godin-Ribuot D.

Ann Cardiol Angeiol (Paris). 2005 Mar;54(2):89-96. Review. French.

PMID:
15828464
47.

Chronic intermittent hypoxia increases infarction in the isolated rat heart.

Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, Béguin P, Godin-Ribuot D, Ribuot C, Launois SH, Bessard G, Lévy P.

J Appl Physiol (1985). 2005 May;98(5):1691-6. Epub 2004 Dec 23.

48.
49.

Heat stress preconditioning and delayed myocardial protection: what is new?

Joyeux-Faure M, Arnaud C, Godin-Ribuot D, Ribuot C.

Cardiovasc Res. 2003 Dec 1;60(3):469-77. Review.

PMID:
14659792
50.

COX-2: an in vivo evidence of its participation in heat stress-induced myocardial preconditioning.

Arnaud C, Joyeux-Faure M, Godin-Ribuot D, Ribuot C.

Cardiovasc Res. 2003 Jun 1;58(3):582-8.

PMID:
12798431

Supplemental Content

Loading ...
Support Center